Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 11Terminated 6Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma 1

Interventions

pembrolizumab 223Cyclophosphamide 193Nivolumab 186Radiotherapy 182Carboplatin 155Paclitaxel 114Dexamethasone 111Cisplatin 111Radiosurgery 103Magnetic Resonance Spectroscopy 98Surveys and Questionnaires 90Ipilimumab 84Doxorubicin 80durvalumab 77Lenalidomide 77Rituximab 75atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 67venetoclax 65Etoposide 65Specimen Handling 64Capecitabine 64Bevacizumab 63Oxaliplatin 61Docetaxel 60Biopsy 58Fluorouracil 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × paricalcitol × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡